This article showcases our top picks for the best London based Pharmaceutical companies. These startups and companies are taking a variety of approaches to innovating the Pharmaceutical industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top London Pharmaceutical Companies
GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people.
GSK’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies.
The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries.
The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.. .
Huma is a global health tech company with a mission to help people with chronic, complex, and rare diseases to live longer, better lives. Huma works with world-leading healthcare providers, pharmaceutical, insurance and technology companies, including Apple and Tencent, to build a connected digital health ecosystem.
Headquartered in London, Medopad has offices in the US and China.. .
The company’s openreach segment provides fiber broadband, passive infrastructure access, wholesale line rental, local loop unbundling, Ethernet, passive infrastructure access, and mobile infill infrastructure solution services as well as products that connect exchanges to communications providers’ networks. BT also retails technology equipment; and provides systems integration, fleet management, and payment services as well as audio, video, and web conferencing, and collaboration services.
BT Group plc was incorporated in 2001 and is based in London, United Kingdom.. .
Autolus is in T-cell programming and manufacturing technology and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both hematological cancers and solid tumors. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer.
The company’s pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and others.. .
Synthace’s goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable.
Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.. .
Lifebit CloudOS is an intelligent genomics platform that understands DNA data and generates meaningful insights like humans do. This offers researchers, and their organisations (ie.
top tier pharmas), a highly scalable, modular and reproducible system that automates the analysis processes, learns from the data via AI and provides actionable insights.. .
Causaly is an AI for Biomedical Cause & Effect discovery, empowering researchers and decision makers to quickly find causal evidence and generate insights from vast amounts of documents. The company is developing a machine-reading platform that turns free-flow text into causal knowledge graphs and applies machine learning to surface new knowledge.
This helps users to accelerate their research schedules and improve time-to-insight significantly.. .
Their combined solution will allow companies to automate complex business processing and automatically generate affiliated finance and compliance reports. To find out more or discuss your use case with us, visit: www.arria.com..
At Echo, we believe health is about people not pills. That’s why we’ve created a new kind of pharmacy.
One that comes to you, not the other way around. We start with being brilliant at fulfilling prescriptions, because getting people taking the right medicine is the first step in staying well.
But there’s more we can do. It’s not just patients we support, its partners.
Together with other like-minded pharmacies, GPs and prescribing services we deliver even more positive experiences. Ultimately, we want to help patients understand and do more for themselves, so together they can make the right decisions with their GPs.
And when it comes time to improve our health, we all know more Technology should make the future of health care more human. So ours comes packed with care..
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect, so that breakthroughs happen faster.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK..
Every kit has a set of readily available experiments to spark curiosity. The number of experiments is only limited by one’s creativity! Twin digital application consists of interdisciplinary courses that expose the kids to scientific concepts.
This platform also provides a community, where Twinners can share and celebrate their experiments and learn together. In the advanced stages, using patterns of the children from their digital journey, Twin will offer a customized learning path for each child.
Skipping Rocks Lab
Skipping Rocks Lab is a London-based startup that develops natural and biodegradable packaging for liquids made from seaweed extract. It has developed Ooho!, an edible water bottle alternative to plastic bottles.
Skipping Rocks Lab was co-founded by graduates from Imperial College and Royal College of Art and is currently incubated in the Climate KIC accelerator.. .
BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing.
The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease.
The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada.
The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995.
Its headquarters is in London in the United Kingdom.. .
ADVANZ PHARMA is a global pharmaceutical company focussed on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche established medicines. The Company has an international footprint with sales in more than 100 countries and has a diversified portfolio of more than 200 established, off-patent molecules that make up more than 1,300 SKUs.
It also markets orphan drugs through its Orphan Drug Division, currently consisting of Photofrin for the treatment of certain rare forms of cancer, which is currently undergoing testing for potential new indications.. .
Its headquarters is in London in the United Kingdom.. Mereo’s internal expertise is complemented by a unique partnership with a leading global CRO, ICON.
Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products.
Small Pharma applies expert intellectual property design to guide academic discovery to commercial product. We operate a scalable model of outsourced drug development.
We assemble specific expert teams to design and execute development programs with demonstrated track-records in all disciplines essential to their success.. .
Liver cirrhosis kills more than a million people a year. More than 650 million people around the world suffer from chronic liver disease, costing economies €15.8 billion annually.
Yaqrit Limited is developing a family of liver disease treatments that will transform the lives of these patients. Today, there are few options for treatment.
Antibiotics and laxatives, which target gut bacteria and bacterial products, or a liver transplant are the standards of care. The drawbacks of widespread antibiotic use are well-known, and waiting lists for transplants are long – in the UK, for example, 30% of patients on the waiting list have been there for more than two years..
By analysing a range of obvious and non-obvious digital sources the profile identifies what skills a person acquires now and what he/she needs to improve in order to qualify for a particular occupation.. .
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives.
With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S.
(whose registered office is in France).. .
Phlo is a digital pharmacy delivering NHS & Private prescriptions when and where you need them. We work with both repeat and acute (one-off) prescriptions.
We use cutting-edge technology and analytics to place patients at the heart of our business, providing patients with real-time, on-demand delivery of their acute and repeat prescriptions.. .
Polymateria was founded in 2016 and is headquartered in London, England, UK.. .
Closed Loop Medicine
Closed Loop Medicine (CLM) is a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. The company combines proven drugs with proprietary digital therapeutics enabling the digitisation and data capture of an entire care continuum.
CLM has a pipeline of regimes in development that integrate Digital + Drug + Device for the treatment of some of the biggest challenges facing 21st century health systems – sleep disorders, hypertension, chronic pain and diabetes.. .
Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner.
Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective..
LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.
LIfT BioSciences was founded in 2016 and headquartered in London, England.. .
Veristat is an innovative full-service, science-focused clinical research organization (CRO) with over 20 years of experience in supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Veristat offers comprehensive clinical development services, including biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management, for a single study or an entire clinical program, as well as preparation of integrated summary documents and submission-ready CDISC data for regulatory filings.
Due to Veristat’s unwavering commitment to scientific integrity, client focus and exceptional performance, long-lasting client relationships are our hallmark.. .
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications). The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g.
systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. In addition to the above main focus, it is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health and other disease areas.
It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.. .
By combining the power of play and strong platform analytics, we are able to influence purchases while collecting valuable live shopper insights and linking offline behaviours with online profiles. To date, Ksubaka has helped retailers and brands deploy more than 10,000 playSpots touch screens in 150 cities and 1500+ store locations.
Our platform records nearly 2 billion data points each month, delivering real-time customer insights to our clients. Ksubaka works with some of the world’s leading retailers, including Tesco, FairPrice, Coles, Auchan, CR Vanguard, WuMart, Evergrande Group and many others, and major brands including Topshop, Coca-Cola, Colgate, Dove, Head and Shoulders, Johnson & Johnson, Heineken, GSK, Kellogg’s, Lifebuoy, L’Oreal, Paris, Nescafe, Nestle, Oreos and Sunsilk.
We are headquartered in London and have an office in Singapore serving clients across the region. “Ksubaka creates the ideal confluence of the power of retail, the power of data and the magic of gamified experiences.” – Rahul Welde, EVP Digital Transformation, Unilever.
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry.
The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.. Everything else is taken away to be swiftly returned – easing the hassle of returns for both customers and retailers..
Keller has permanent operations in more than 40 countries, around 10,000 employees and a combined turnover of around £1.6 billion.. Don’t pay recruitment fees upfront, let us help you pay the invoice over 6 months, whilst we pay your recruitment agencies on day 1, keeping them delighted in the process! So, stop paying big fees upfront and stop looking for the best recruitment agencies to work with, we will help you scale your SME to new heights by paying with Playter..
Google Analytics confirms their website has over 20,000 unique visitors per month. The structure ensures each expert holds exclusivity for their area of expertise and country.
They do this to avoid repetition and competition. The structure also ensures each expert receives maximum online exposure..
Firza is a medical company modernizing healthcare using technology-enabled, bespoke workforce solutions. The company also specializes in robotic process automation, artificial intelligence, and technology backed workforce solutions for Primary Health Care.
They providing real-world commercial and clinical solutions to the NHS, GP Practices, Pharmacies, and healthcare organizations across the country. Firza’s experience of working in General Practice enables them to mobilize quickly and respond with viable solutions that suit the individual needs of the practice team.
They deliver technology and digital services for the modern-day General Practice. Firza was founded in 2014 and is headquartered in London, England, United Kingdom..
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well as safe and effective TCRs against these tumour targets for therapeutic application.
Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.. .
Quercus Investment Partners’s know-how allows it to construct and manage projects to a high level of quality throughout their lifespan, thereby maximising returns for its investors.. We do not believe that one size fits all.
We adopt a fully – integrated approach to ensure a product-market – fit by working with our partners to understand their subscribers from day one, integrating data sets and determining which technologies are most appropriate for each device type, usage habits and demographic.. .
Acellera is a company devoted to speed up drug discovery and development. Acellera is focused on delivering services and solutions to companies and academic institutions on computing intensive, mission critical applications.
By exploiting heavy optimization techniques and the outstanding computational capabilities of new accelerator processors, they help to achieve performances which would be otherwise unreachable using current standard technology. Acellera is a company with more than 10 years of experience speeding up drug discovery and development with computer assisted methods..
For more information on how we can accelerate your journey into the subscription economist, visit www.limio.com.. .
Smart Surgical Appliances
Smart Surgical Appliances is a medical device company that develops sensor-enabled surgical instruments designed to reduce costs, improve safety, and minimize risk in keyhole surgery. The company intends to improve the safety and clinical efficacy of the minimally invasive surgery like keyhole surgery, endoscopic surgery, and the natural orifice transluminal endoscopic surgeries.
It provide real-time sensing and feedback from the operative site akin to ‘touch and feel’.. .
To accommodate this growing demand we’ve built Soply; an advanced platform empowering companies to more efficiently outsource projects to creative freelancers and receive visual content at scale. But we’re not just a marketplace.
Through the combination of human and artificial intelligence we will be able to provide companies and agencies with intelligent visual content at highly efficient workflows.. .
European Medicines Agency
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in London. It began operating in 1995.
The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU. EMA protects public and animal health in 28 EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality..
Stabilitech is a privately held company focused on stabilisation of sensitive biological molecules, such as vaccines and biopharmaceuticals. The company was founded by Dr Jeff Drew, and started research operations in 2004.
Stabilitech is based at the London Bioscience Innovation Centre, London UK. Stabilitech’s goal is to improve the stability of vaccines and biopharmaceuticals using their proprietary formulation technology.
Stabilitech’s technology permits the long-term stabilisation of a wide range of thermally sensitive viruses, vaccines and biopharmaceuticals. Excipient compositions contain only chemical ingredients already used in clinical settings, approved injectables or on the Generally Regarded As Safe (GRAS) list.
Their business model is to establish partnerships with major pharmaceutical and biotechnology companies, as well as with global health organisations, to commercialise their technology.. Building a worldwide movement for a ‘new operating system for change’.
A marketplace for continual growth and the global authority for AQ.. .
Morria Biopharmaceuticals Plc, a biopharmaceutical company, engages in the discovery and development of non-steroidal, synthetic anti-inflammatory drugs termed Multi-Functional Anti-Inflammatory Drugs. The company’s products in Phase 2a clinical pipeline include MRX-4, a nasal spray for treating allergic rhinitis or hay fever, as well as MRX-6, a topical cream for treating contact dermatitis, a common type of eczema.
Its product candidates in pre-clinical studies comprise OPT-1 for the treatment of conjunctivitis and dry eye; MRX-5 used in the treatment of inflammatory bowel disease; and CFX-1 for the treatment of cystic fibrosis. The company is headquartered in London, the United Kingdom..
The platform supports many order and self-checkout scenarios including: order food and drinks to beat the queue and pick up straight away (e.g. in-office cafeterias, high street cafeterias, arenas/stadiums, pubs) self-checkout for your food and drinks skipping the queue totally pre-order food and drinks to your seat (e.g.
on a train) self-checkout at the pump in a petrol station self-checkout at the table at a restaurant buying tickets without the need to use a ticket machine self-checkout at the shelf in a retail store buying from a poster plus many more Any mobile wallet (a payment app), including retailers own branded apps, can be integrated and work on the WoraPay platform. Therefore, retailer’s clients are able to select their favourite or preferred mobile wallet instead of having to download a new one each time from individual retailers.
WoraPay has been recognized by The FinTech50 as one of the hottest FinTech start-ups to watch in Europe. WoraPay was selected in the top 10 from over 350 applicants world wide for Startupbootcamp FinTech London 2015 Accelerator which has accelerated our UK launch.
SomaNautix is a spin out of the Battaglia Research group, University College London. Prof.
Battaglia has been fascinated over many years by the powerful capability of viruses to penetrate cells. Applying some of the structural features of viruses to polymer constructs has resulted in the highly versatile, molecular engineered endoNaut technology for therapeutic rather than pathogenic purposes.
Somanautix focuses on oncology product development for rare tumours (brain and peritoneal).. .
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. Spasticity is a debilitating and painful symptom that consists of involuntary spasms and stiffness of limbs and torso.
The goal of the Canbex lead programme is to improve the lives of people with this serious and incurable disorder, and set a new standard in the treatment of spasticity.. .
Oxford Phamascience Group
Oxford Pharmascience Group Plc uses a range of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take. The Company does not manufacture or sell its own pharmaceutical products direct to consumers but instead seeks to license its technologies and dossiers to a network of partners, mainly leading pharmaceutical companies with Rx (prescription) and OTC (Over the Counter) branded portfolios.
Oxford Pharmascience Group Plc focuses on existing medicines that are proven to be safe and effective but nevertheless still have associated issues and side effects often affecting compliance. By working with such medicines the Company is able to develop new innovative products for a fraction of the cost, in much quicker timescales and without the high risk of failure associated with developing new drugs..
The revolution of the AI is not possible without the integration of all the radiology necessities into a single place. A secure, fast, compliant, with unlimited storage and FREE (for research only, ask for the normal price) PACS service running over the Google Cloud infrastructure.
Keep in all the features without taking you data out of your region.. .
Retailers use the services to organise and enrich their product data and to enable marketers and media partners to build baskets at their webstores. Our customer list includes major CPG and GM manufacturers such as Unilever, Diageo, P&G, AB InBev, etc.; major digital publishers such as NewsLife, BBC Worldwide, etc.; and more than ten of the world’s biggest retailers, including Walmart, Woolworths, Ahold and Tesco..
Internis is an exciting and innovative British start-up business. Founded in 2010, it is a pharmaceutical company engaged in the development and commercialisation of highly effective and innovative new medicines aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency.
Internis supplies a prescription only licensed medicine (FultiumD3) to treat patients with a vitamin D deficiency. Vitamin D is offered to at-risk groups on prescription to prevent the health risks associated with a deficiency or insufficiency.
It is estimated that up to a quarter of the population in the UK have low levels of vitamin D in their blood – with deficiency linked to conditions including bone deformities and health complications such as depression, joint pain, migraines, fatigue and a weakened immune system.. .
Stealthyx Therapeutics Ltd. is developing a unique, safe, patented drug-targeting platform technology capable of drug delivery only at sites of disease.
It will significantly improve the pharmacokinetic, pharmacodynamic and therapeutic properties of biological agents.. .
Traditionally landlords would expect to pay upwards of £1000 to let their property, Upad landlords receive this service for just £120. Upad landlords have more control and can select the most suitable tenant, which often leads to a longer lasting tenancy.
Research conducted in 2014 by independent research specialists BDRC stated that Upad landlords suffered 45% less rent arrears compared to non-Upad landlords. Upad have an army of loyal customers who have done everything from leave more than 600 five star reviews on Trustpilot to investing over £1m directly into the business..
Prescient Healthcare Group
Prescient is a product strategy and decision support consultancy that helps clients make better clinical and commercial decisions, resulting in enhanced outcomes for patients, customers and shareholders. Founded in London in 2007, Prescient has since expanded its global reach through offices in New York, San Francisco, New Delhi and Beijing.
Prescient partners with most of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech organizations.. .
Feel free to reach out if you want to hear more.. .
Hammersmith Medicines Research Ltd
HMR is a Contract Research Organisation (CRO). They specialize in and can provide a full service for phase 1 and early phase 2 studies.
Their premises are spacious (5800 m²) and have 100 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. They have 150 staff – 8 physicians, 35 nurses or nurse graduates, and 95 graduates or PhD.
They have done over 550 studies since 1993.. .
gweek’s vision is a world that values the power of genuine communication between people. Our communication skills are our personal currency! The rise of soft skills and our urgent need for them, is now finally recognised as surpassing our need for technical skills.
We are all Speech Intelligent. In today’s world we need to be agile, adaptive and authentic communicators.
Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, we have in a few years established ourselves as an authoritative provider of new life science information, insights and intelligence..
Their approach and platform are unique in that they are built on consumer data ownership to generate trust and transparency. Customers can enhance loyalty, increase retention, and drive profits without personal data risk.
They prove that data trust drives better business results. Their businesses are seeing value of up to: – +30% customer (user) return rates – +3% customer growth They closed a 3 business Beta in May 2015.
At Sep 30, they have 27 customers and over 4,300 users. Recent metrics: – 71% m/m user growth – 87% m/m usage (transaction) growth.
Evaluate provides trusted commercial intelligence for the pharmaceutical and medical device industries. Our EvaluatePharma® online subscription services provides a seamless view of the past, present and future of the global pharmaceutical market in a single, standardised platform.
Vantage – our award-winning, independent editorial team – provide thought-provoking news and insights into the current and future developments in the industry. Evaluate has been a trusted partner to industry-leading organisations for over 20 years.
For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com.. .
APCER Life Sciences
APCER Life Sciences provides comprehensive drug safety/pharmacovigilance, medical information, medical writing, regulatory services, quality assurance and risk management programs to pharmaceutical and biotech companies globally. We bring medicinal / scientific expertise through our healthcare professionals & physicians and address full pharmacovigilance requirements for North America, UK & Europe markets.
Our clients benefit from our vast experience in regulatory submissions across 100+ countries and consultative approach towards audit /inspection readiness. Our focus towards Patient safety and Risk profile management makes us the preferred choice for pharma companies who are looking for pre /post marketing compliance & reporting solutions.
We have scalable operations across five global offices which house more than 750 employees: Princeton, NJ, USA; London, UK; Germany, Wan Chai, Hong Kong, New Delhi and Ahmedabad, India.. Its unique approach to the footwear market marries the desire for fashion-forward and design-led shoes with the practicalities of comfort to deliver an innovative and highly personalised shopping experience..
Eden Pharma is a boutique research and development company focused on cannabis. The company offers medicinal marijuana services with various applications—medically, industrially, and recreationally.
Eden Pharma also runs an online store where its award-winning CBD products are available for sale. A Dedicated Team Leading the Way Eden Pharma is led by a highly experienced team.
They have a high level of professional knowledge in all aspects of the cannabis industry, including research and development, investment, sales, finance, and the technology behind the creation of high-quality products. For this reason, Eden Pharma is taking the cannabis sector by storm.
The company’s managerial and operational staff members dedicate their efforts to a robust corporate culture that involves collaboration, enthusiasm, and growth. Their dedication and a strong sense of social responsibility drive the company forward and attract top employees and clients.
Responsibly Maximizing Growth As more and more countries are legalizing the medicinal and recreational use of marijuana, Eden Pharma is honored to be one of the leading companies in a rapidly growing global market. The company is actively concentrating on research and development.
It sees this as the focal point of this revolutionary industry. One of the main operational goals is to produce innovative, low-carbon, environmentally friendly technology that will take care of the earth and maximize output to cater to the needs of commercial, pharmaceutical, and industrial clients.
Sinclair Pharma plc
Sinclair Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products.
Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company’s product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology..
PHASTAR work with small and large pharmaceutical and biotechnology companies to provide statistical consulting and to summarise, analyse and report clinical trials. Their top priority is the quality of our work, ensuring they give you the best statistical advice, and analyse your clinical data optimally, getting it right first time.
There are lots of different ways to analyse a set of data. they can advise on how to get the most out of your data.
Statistics is an art!. In addition, our class leading Hosting, Connectivity and Disaster Recovery services are comprehensively supported by our stringent programme of monitoring, management and process control.
For more information, please visit our website: www.controlcircle.com Benjamin Radomski ControlCircle +44 (0) 207 517 6510 [email protected] Web: www.controlcircle.com. Developed at Columbia Business School and London Business School, Millie brings tutors and tech to you so that learning feels as comfortable as chatting over coffee.
We support all students One of every ten students receives Millie education for free. We’re committed to creating a positive social impact and uniting our world across borders.
We believe in the power of lifelong learning, the strength of community, and the potential of each individual.. .
ProClinical is a leading global recruitment company that operates exclusively within the life sciences industry. They have a proven track record of having filled thousands of permanent and contract vacancies at pharma, biotech and medical device companies, contract research organisations (CROs) and other life sciences companies in Europe, Asia and the USA.
Their satisfied customers include leading global brands, small to medium sized enterprises and emerging start-ups.. .
Kinapse bring industry insights and technical expertise throughout their engagements. They develop actionable recommendations and innovative solutions which are implemented successfully.
their clients are the world’s leading life sciences organisations, their customers, suppliers and regulators. their client references are the strongest testament to the exceptional results They deliver in partnership with them.
They are one global business with expert teams providing excellent services With over 500 professionals worldwide, They select their teams to deliver the best possible solutions. their deeply held values and operational processes drive their teams to ensure excellent client service on all their engagements..
AMCo manufactures and distributes generic pharmaceutical prescription products for distributors, wholesalers, hospitals, pharmacies, patients, and doctors worldwide. It offers therapeutic products, including endocrinology, ophthalmology, and urology products in various dosage forms and delivery systems.
The company also offers Nefopam, a non-narcotic painkiller for the treatment of persistent pains. It sells its products directly and through a network of third party distributors..
Founded in 2017, performance.io are a performance marketing agency on a mission to deliver health, tech and consumer brands the online ROI they deserve. Their HQ can be found on the Holborn – right in the heart of London – as well as on 5th Avenue, in New York City.
On top of that they just expanded their scope with a team in Kolkata, the cultural capital of India. With plans to open their Sydney office next year you can see that they are getting things right when it comes to customer experience (CX).
And if they nail it for you, it means you nail it with your customers. Everyone’s happy.
And if they make a mistake, what they do is empirical; they can identify what went wrong and fix it.. .
Intract Pharma Limited is an oral drug delivery licensing and product development company offering a range of proprietary formulation technologies to deliver novel and optimised therapeutics targeted to patient needs. The company is a spin-out of University College London, and is centred around over 15 years of research and innovation from the laboratory of Professor Abdul Basit.
Intract’s range of formulation technologies includes Phloral™ for colon targeted delivery, and ProRelease™, a versatile microparticulate delivery system. Complementary to these, Intract has developed unique gastrointestinal (GI) models, which closely reflect the physiological environment of the human GI tract, enabling accurate and predictable in vitro-in vivo correlation..
Theramex is a global specialty pharmaceutical company dedicated to women and their health.. It takes the hassle out of gifting, allowing users to send real gifts to anyone, even without knowing their postal address.
Sending is fast and effortless: A user simply selects a Recipient from their Phones Contacts; and then selects a gift from the SwiftGift online store (prices range from £1-£22,500). SwiftGift reaches out to the Recipient to obtain their postal address and dispatches the gifts to them.
Gifts arrive beautifully packaged and with a personalised message from the Sender, while the Recipient’s address remains private and protected. Available in UK store: appsto.re/gb/0b607.i.
SkyePharma is a speciality drug delivery company with a proven range of oral and inhalation technologies. SkyePharma strives to deliver a clinical benefit for patients by using its multiple delivery technologies to create enhanced versions of existing pharmaceutical products as well as products incorporating new chemical entities.
Combining established pre-clinical, clinical and regulatory expertise with the capability to formulate and manufacture drugs, both for clinical studies and commercial sale, SkyePharma identifies and develops potential new therapeutic products for out-licensing as well as working with partners to develop their concepts through to marketable products.. .
In additon we have a kitchen, with great coffee and a selection of teas, lockers and printing facilities. Sitting at the same desk 9-5 all day every day reduces your productivity significantly..
We decided we needed an easier way to keep our dogs happy. WufWuf was founded not only to make it EFFORTLESS for you to provide the best products for your dog, but also to make it easier to afford.
This makes it simpler than ever to provide consistent stimulation to your furry family member – resulting in a healthier happier dog. By choosing quality items for your monthly box, our mission is to ensure you won’t have to worry about choice and variety, but rather can enjoy each WufWuf delivery with your pup..
Arrow Therapeutics was founded in 1998 and is already making a significant contribution to anti-infective drug discovery. Microbial resistance to existing drugs is an ever increasing threat that is leading to serious unmet medical need and incurring a huge financial burden on society.
Despite the huge challenges of this situation it also presents excellent opportunities to combine scientific research and business. As more and more big pharma groups concentrate their efforts on drug development, greater chances are open to smaller companies such as ours to show their excellence in research..
• View important details such as job descriptions, start and end times, hourly rates and more. • Books shifts on demand and on your own terms.
• Receive notifications of job confirmations, shift changes and new vacancies. • Go paperless and submit electronic time-sheets directly via the app.
Our cloud based portal allows healthcare organisations (employers) to: • Recruit locums into staff bank. • Post and manage vacancies.
Innoture develops and manufactures microneedles and microneedle patches for use in drug delivery, diagnostics and monitoring. Innoture’s microneedle technology allows for pain-free and highly efficient transdermal substrate delivery and provides an extremely flexible, simple and cost effective solution applicable to many transdermal scenarios.
Innoture’s IP allows freedom to operate within the crowded microneedle landscape and offers a truly adaptive, tailored, application optimised solution. Research and development is based at the state-of-the-art institute of Life Science Swansea University and there is a knowledge transfer partnership in place with the Biocomposites Centre at Bangor University.
The company is backed by a range of notable investors from the pharmaceutical industry.. .
Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases.
Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.. .
Accunea is a medical device business that is developing novel point-of-care diagnostic and monitoring technologies for clinical centres. Their premiere product is a bedside multi parameter organ function monitoring device that provides unprecedented capabilities for monitoring kidney function and metabolic condition both pre- and post-transplantation.
Kidney transplantation is the only cure for dialysis-dependent renal failure each one saving lives and saving money for healthcare systems, but the function of the organ being implanted is often unknown until after surgery. Jez Marston, Nick Housby, and Dr.
Robert Learney have collaborated to build Accunea around the patent-pending RenoSure real-time kidney function monitoring technology initially developed by Dr. Learney during his PhD research at Imperial College London.
The device has been tested and verified in blood samples in the laboratory and in a blood-perfused pig kidney model of injury. Accunea Ltd.
is in the process of raising funds to take the RenoSure device forward into pre-clinical trials.. The platform comes with many value-added services such as API, reporting, diagnostics, and much more.
In the future they will add artificial intelligence and machine learning features to the platform that help their customers to get the best possible carrier deals for their eSIM cards. 1oT is part of, and co-founded by Mobi Solutions group (http://mobisolutions.com) which among other things was a key developer of the original Skype mobile application, as well as launching the carrier billing service Fortumo, (https://fortumo.com, backed by Intel Capital), and Messente (https://messente.com), the critical business SMS platform service global clients..
Proteome Sciences is a London (UK) and Frankfurt (Germany) based SME with expertise in proteomics and biomarker research. We have discovered and patented a large number of novel protein biomarkers for diagnosis, prognosis and treatment of key human diseases including neurodegenerative disorders, cancer, stroke etc.
and provide protein biomarker services to pharmaceutical and diagnostics companies.. .
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.The orexin system is a key regulator of behavioural arousal, wakefulness and sleep. The loss of the orexin neurons has been shown to be strongly linked to multiple neurological conditions including narcolepsy.
In this indication, orexin receptors remain intact and functional, providing an opportunity for therapeutic intervention.. .
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs.
We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic..
From small boutique hotels to the world’s largest luxury class hotels, HTI can match your business needs with both off-the-shelf products and tailor-made luxury solutions to suit the most demanding guests from the business traveller to the casual holidaymaker. Their customers include some of the world’s most famous hotel brands including Accor, Banyan Tree, Comfort Hotels, Hilton, IHG, Jumeirah, Lucien Barriere, Marriott, Melia, Starwood, Virgin and Wyndham, as well as many more luxurious independent hotels..
You may write to us at: BestStartup.co.uk/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.